Prophylactic intra-aortic balloon pump before ventricular assist device implantation reduces perioperative medical expenses and improves postoperative clinical course in INTERMACS profile 2 patients

Circulation Journal

Volumn 79, Issue 9, 2015, Pages 1963-1969

  Imamura, Teruhiko ^a   Kinugawa, Koichiro ^a   Nitta, Daisuke ^a   Hatano, Masaru ^a   Kinoshita, Osamu ^a   Nawata, Kan ^a   Kyo, Shunei ^a   Ono, Minoru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cost; Heart failure; Intra aortic balloon pump; Ventricular assist device

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; HEALTH CARE COST; HEART FAILURE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; INTRAAORTIC BALLOON PUMP; LENGTH OF STAY; MALE; VENTRICULAR ASSIST DEVICE; BLOOD; CLINICAL TRIAL; COST; ECONOMICS; HEART ASSIST DEVICE; MIDDLE AGED; PROCEDURES;

ADULT; BILIRUBIN; COSTS AND COST ANALYSIS; CREATININE; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED;

EID: 84940062745     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0122     Document Type: Article

References (35)

1. Ferrari G, Gorczynska K, Mimmo R, De Lazzari C, Clemente F, Tosti G, et al. IABP assistance: A test bench for the analysis of its effects on ventricular energetics and hemodynamics. Int J Artif Organs 2001; 24: 274-280.
2. Parissis H. Haemodynamic effects of the use of the intraaortic balloon pump. Hellenic J Cardiol 2007; 48: 346-351.
3. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL Jr. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968; 203: 113-118.
4. Christenson JT, Licker M, Kalangos A. The role of intra-aortic counterpulsation in high-risk OPCAB surgery: A prospective randomized study. J Card Surg 2003; 18: 286-294.
5. Joskowiak D, Szlapka M, Kappert U, Matschke K, Tugtekin SM. Intra-aortic balloon pump implantation does not affect long-term survival after isolated CABG in patients with acute myocardial infarction. Thorac Cardiovasc Surg 2011; 59: 406-410.
6. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomised, open-label trial. Lancet 2013; 382: 1638-1645.
7. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-1296.
8. Dziewierz A, Siudak Z, Rakowski T, Kleczynski P, Zasada W, Dudek D. Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock. Postepy Kardiol Interwencyjnej 2014; 10: 175-180.
9. Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, et al. A systematic review and meta-analysis of intraaortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? Eur Heart J 2009; 30: 459-468.
10. Romeo F, Acconcia MC, Sergi D, Romeo A, Muscoli S, Valente S, et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: A comprehensive meta-analysis. Am Heart J 2013; 165: 679-692.
11. Nabawi F, Santarpino G, Pfeiffer S, Fischlein T. Beneficial effect of preoperative intra-aortic balloon pumping in patients with low-ejection fraction undergoing coronary artery bypasses grafting. Thorac Cardiovasc Surg 2012; 60: 56.
12. Christenson JT, Simonet F, Badel P, Schmuziger M. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 1999; 68: 934-939.
13. Ranucci M, Castelvecchio S, Biondi A, de Vincentiis C, Ballotta A, Varrica A, et al. A randomized controlled trial of preoperative intraaortic balloon pump in coronary patients with poor left ventricular function undergoing coronary artery bypass surgery. Crit Care Med 2013; 41: 2476-2483.
14. Creswell LL, Rosenbloom M, Cox JL, Ferguson TB Sr, Kouchoukos NT, Spray TL, et al. Intraaortic balloon counterpulsation: Patterns of usage and outcome in cardiac surgery patients. Ann Thorac Surg 1992; 54: 11-18, discussion 18-20.
15. Holman WL, Li Q, Kiefe CI, McGiffin DC, Peterson ED, Allman RM, et al. Prophylactic value of preincision intra-aortic balloon pump: Analysis of a statewide experience. J Thorac Cardiovasc Surg 2000; 120: 1112-1119.
16. Yildirim Y, Pecha S, Kubik M, Alassar Y, Deuse T, Hakmi S, et al. Efficacy of prophylactic intra-aortic balloon pump therapy in chronic heart failure patients undergoing cardiac surgery. Artif Organs 2014; 38: 967-972.
17. Pfeiffer S, Santarpino G, Sirch J, Fischlein T, Vogt F. Does prophylactic intra-aortic balloon pumping really fail to improve perioperative outcomes in patients with poor left ventricular function? Crit Care Med 2014; 42: e728-e729, doi:10.1097/CCM.0000000000000557.
18. Norkiene I, Ringaitiene D, Rucinskas K, Samalavicius R, Baublys A, Miniauskas S, et al. Intra-aortic balloon counterpulsation in decompensated cardiomyopathy patients: Bridge to transplantation or assist device. Interact Cardiovasc Thorac Surg 2007; 6: 66-70.
19. Kinugawa K. How to treat stage D heart failure?: When to implant left ventricular assist devices in the era of continuous flow pumps? Circ J 2011; 75: 2038-2045.
20. Imamura T, Kinugawa K, Hatano M, Fujino T, Inaba T, Maki H, et al. Status 2 patients had poor prognosis without mechanical circulatory support. Circ J 2014; 78: 1396-1404.
21. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant 2014; 33: 555-564.
22. Sawada Y, Ohtomo N, Tanaka Y, Tanaka G, Yamakoshi K, Terachi S, et al. New technique for time series analysis combining the maximum entropy method and non-linear least squares method: Its value in heart rate variability analysis. Med Biol Eng Comput 1997; 35: 318-322.
23. Imamura T, Kinugawa K, Nitta D, Fujino T, Inaba T, Maki H, et al. Lower rotation speed stimulates sympathetic activation during continuous- flow left ventricular assist device treatment. J Artif Organs 2015; 18: 20-26.
24. Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, et al. Intra-aortic balloon counterpulsation in cardiogenic shock: Report of a co-operative clinical trial. N Engl J Med 1973; 288: 979-984.
25. Frye RL, Braunwald E. Studies on Starling's law of the heart. I: The circulatory response to acute hypervolemia and its modification by ganglionic blockade. J Clin Invest 1960; 39: 1043-1050.
26. Imamura T, Kinugawa K, Hatano M, Fujino T, Inaba T, Maki H, et al. Low cardiac output stimulates vasopressin release in patients with stage d heart failure. Circ J 2014; 78: 2259-2267.
27. Mizuno M, Sato N, Kajimoto K, Sakata Y, Minami Y, Munakata R, et al. Intra-aortic balloon counterpulsation for acute decompensated heart failure. Int J Cardiol 2014; 176: 1444-1446.
28. Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, et al. Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device. Circ J 2012; 76: 1895-1903.
29. Loforte A, Marinelli G, Musumeci F, Folesani G, Pilato E, Martin Suarez S, et al. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: Treatment strategies and analysis of risk factors. Artif Organs 2014; 38: E129-E141.
30. London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013; 309: 1704-1713.
31. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-361.
32. Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, et al. Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J 2013; 77: 96-104.
33. Sloth E, Sprogoe P, Lindskov C, Horlyck A, Solvig J, Jakobsen C. Intra-aortic balloon pumping increases renal blood flow in patients with low left ventricular ejection fraction. Perfusion 2008; 23: 223- 226.
34. Imamura T, Kinugawa K, Shiga T, Kato N, Endo M, Inaba T, et al. How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients? J Artif Organs 2012; 15: 395-398.
35. Boudoulas KD, Bowen T, Pederzolli A, Pfahl K, Pompili VJ, Mazzaferri EL Jr. Duration of intra-aortic balloon pump use and related complications. Acute Card Care 2014; 16: 74-77.